Copy Link Print Information

SCH772984

193 Cited Publications
Avis client

Based on 193 publication(s) in Google Scholar

SCH772984 is a highly selective and ATP-competitive ERK inhibitor, with IC50s of 4 and 1 nM for ERK1 and ERK2, respectively. SCH772984 has antitumor activity in MAPK inhibitor-na?ve and MAPK inhibitor-resistant cells containing BRAF or RAS mutations.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 99.83%
  • CAS No.: 942183-80-4
  • Formule: C33H33N9O2
  • Masse moléculaire:587.67
  • Stockage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 1 year , -20°C, 6 months
  • SCH772984 Chemical Structure
    SCH772984 Chemical Structure
  • Experimental Validation Results for SCH772984
  • Experimental Validation Results for SCH772984
  • Experimental Validation Results for SCH772984
  • Experimental Validation Results for SCH772984
  • Experimental Validation Results for SCH772984
  • Experimental Validation Results for SCH772984
  • Experimental Validation Results for SCH772984
  • Experimental Validation Results for SCH772984
  • Experimental Validation Results for SCH772984
  • Experimental Validation Results for SCH772984
  • Experimental Validation Results for SCH772984
  • Experimental Validation Results for SCH772984
  • Experimental Validation Results for SCH772984
CAS No.: 942183-80-4
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Solvant et solubilité
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) SCH772984

More
Customer Validation & Images
WBIF
  • WB
  • WB
  • WB
  • WB
  • WB
  • IF
  • WB
  • WB
  • IF
  • WB
  • WB
  • WB
  • WB

Voir tous les produits spécifiques à Isoform ERK

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • SCH772984 Chemical Structure
    SCH772984 Chemical Structure
    1/16
  • 1/16

    SCH772984 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 Feb 13;14(1):802. [Abstract]

    Customer Validation
     SCH772984 upregulates Mbp and Ng2, as well as significantly reduces Cd74 and Erk1/2, in primary neuronal cultures from control and Alzheimer’s disease knock-in mice (Fig. i and j).

  • 1/16

    SCH772984 purchased from MedChemExpress. Usage Cited in: Acta Biomater. 2019 Feb:85:106-116. [Abstract]

    Customer Validation
     Western analysis of related protein expression in the treatment of DBM/CBD-IKVAV-cRGD, DBM/CBD-IKVAV-cRGD + FAK inhibitor PF-573228 or DBM/CBD-IKVAV-cRGD + ERK inhibitor SCH772984.

  • 1/16

    SCH772984 purchased from MedChemExpress. Usage Cited in: Sci Rep. 2019 Jan 29;9(1):907. [Abstract]

    Customer Validation
     HCT116 cells are treated with different concentrations of PD0325901 or SCH772984 before cells are harvested for western blotting analysis for ERK1/2 and phosphorylated ERK1/2

  • 1/16

    SCH772984 purchased from MedChemExpress. Usage Cited in: Sci Rep. 2019 Jan 29;9(1):907. [Abstract]

    Customer Validation
     HCT116 cells are first treated with different concentrations of PD0325901 or SCH772984 for 36 h and are then treated without or with MG132 for 12 hours before harvested for analysis of the levels of proteins by western blotting using antibodies as indicated.

  • 1/16

    SCH772984 purchased from MedChemExpress. Usage Cited in: Sci Rep. 2019 Jan 29;9(1):907. [Abstract]

    Customer Validation
     KYSE70 cells are first treated with different concentrations of PD0325901 or SCH772984 for 36 hours and are then treated without or with MG132 for 12 hours before cells are harvested for western blotting using antibodies as indicated.

  • 1/16

    SCH772984 purchased from MedChemExpress. Usage Cited in: Cancer Res. 2018 Feb 15;78(4):891-908. [Abstract]

    Customer Validation
     A549 cells are treated with 10 μM SCH772984 (ERK1/2 inhibitor) or DMSO for 16 hr and analyzed for PSC formation by immunostaining

  • 1/16

    SCH772984 purchased from MedChemExpress. Usage Cited in: Theranostics. 2018 Jul 30;8(15):4262-4278. [Abstract]

    Customer Validation
     BV2 cells are pretreated with 0.1% DMSO (Ctrl), JuA (25 µM) or JuA (25 µM)+SCH772984 (10 µM) for 30 min, followed by administration of Aβ42 (5 μM) for 6 h.

  • 1/16

    SCH772984 purchased from MedChemExpress. Usage Cited in: J Immunol Res. 2018 Jun 7:2018:6249085. [Abstract]

    Customer Validation
     The level of p-ERK1/2 expression is suppressed by SCH772984. RAW264.7 cells are preincubated with 1 μM SCH772984 for 2h followed by treatment with 20 μg/mL ox-LDL for 24 h.

  • 1/16

    SCH772984 purchased from MedChemExpress. Usage Cited in: Biochem Biophys Res Commun. 2018 Jan 1;495(1):781-786. [Abstract]

    Customer Validation
     Representative images of migrated cells. HUVECs are pretreated with PD98059 (10 μM), SCH772984 (500 nM) or mock control for 2 h, and seeded in upper chambers of transwell inserts. VEGF (100 ng/ml), Scg3 (1 μg/ml) or PBS in medium with reduced FBS is added to bottom chambers in the presence or absence of the inhibitor. After culturing for 4 or 20 h, cells migrated to the lower surface of transwell membrane are stained with DAPI.

  • 1/16

    SCH772984 purchased from MedChemExpress. Usage Cited in: J Neuroinflammation. 2017 Nov 25;14(1):228. [Abstract]

    Customer Validation
     HSP70 release is reversed by ERK1/2 inhibitor in SH-SY5Y cells. SCH772984 (ERK1/2 inhibitor, 2 μM) is given 15 min. Supernatants are collected and analyzed by western blot (n=3).

  • 1/16

    SCH772984 purchased from MedChemExpress. Usage Cited in: Neurotox Res. 2017 Nov;32(4):535-543. [Abstract]

    Customer Validation
     Lithium promotes autophagy flux by activating MEK/ERK pathway in cells. Original Western blot showing LC3-II and p62 abundance following treatment with lithium in the presence of PD184352 and SCH772984 in neurons. Arithmetic means±SEM (n=5) showing LC3-II abundance following treatment with lithium in the presence of PD184352 and SCH772984 in neurons.

  • 1/16

    SCH772984 purchased from MedChemExpress. Usage Cited in: University of Melbourne. 2017 Sep.

    Customer Validation
     Western blot analysis is performed on protein lysates from exponentially growing melanoma cell lines following 24 hours treatment with 0.1% DMSO as a vehicle control or: GSK1120212 (GSK212) 100 nM; GDC0623 100 nM or SCH772984 1 µM.

  • 1/16

    SCH772984 purchased from MedChemExpress. Usage Cited in: Okayama University. 2015.

    Customer Validation
     Expression of Sema4D and PlexinB1 in various oral squamous cell carcinoma cell lines following the addition of IGF-I. Notably, the addition of IGF-I resulted in increased expression of Sema4D, particularly in HSC-2 and SAS cells. This increase was suppressed when IGF-I was administered in the presence of inhibitors targeting its receptor or downstream signaling pathways. No changes in PlexinB1 expression were observed following the addition of IGF-I.

  • SCH772984